Asherman syndrome (intrauterine adhesions). Intrauterine synechiae
Conditions
Interventions
Intervention 1: Intervention Group 1 received a single-dose injection containing 1 x 10^7 mesenchymal stem cells. A subendometrial injection of a cell suspension, prepared in 1 ml of normal saline, wa
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Secondary infertility or embryo transfer failure due to repeated IUA Desire to become pregnant Age less than 45 years old consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients under 20 years old and over 45 years old Patients who themselves or their spouses have abnormal karyotype or genetic and chromosomal disorders Patients with coagulation problems Patients who have an underlying chronic disease and have to take special drugs Patients whose HIV, HCV, or HBV test results are positive Patients who have a history of asthma and allergies to certain drugs Patients with intrauterine anomalies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intrauterine adhesion rate. Timepoint: Before the intervention and after the intervention. Method of measurement: Using the ultrasound technique, we will evaluate the level of adhesion according to the standards of the American Fertility Association (AFS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Yousefi
Tabriz University of Medical Sciences
Outcome results
None listed